Literature DB >> 2068023

Inhaled corticosteroids in pulmonary sarcoidosis.

M A Spiteri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068023      PMCID: PMC2398817          DOI: 10.1136/pgmj.67.786.327

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  11 in total

1.  Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis.

Authors:  M A Spiteri; S P Newman; S W Clarke; L W Poulter
Journal:  Eur Respir J       Date:  1989-03       Impact factor: 16.671

2.  Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis.

Authors:  M A Spiteri; S W Clarke; L W Poulter
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

3.  Use of budesonide in the treatment of pulmonary sarcoidosis.

Authors:  O B Selroos
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

4.  Relation between immunocytological features of bronchoalveolar lavage fluid and clinical indices in sarcoidosis.

Authors:  G M Ainslie; L W Poulter; R M du Bois
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

5.  Alveolar T-cell subsets in pulmonary sarcoidosis. Correlation with disease activity and effect of steroid treatment.

Authors:  J L Ceuppens; L M Lacquet; G Mariën; M Demedts; A van den Eeckhout; E Stevens
Journal:  Am Rev Respir Dis       Date:  1984-04

6.  Beclomethasone dipropionate.

Authors:  M H Williams
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

7.  The macrophage in sarcoid granuloma formation.

Authors:  M A Spiteri; L W Poulter; D Geraint-James
Journal:  Sarcoidosis       Date:  1989-10

8.  Corticosteroid therapy suppresses spontaneous interleukin 2 release and spontaneous proliferation of lung T lymphocytes of patients with active pulmonary sarcoidosis.

Authors:  P Pinkston; C Saltini; J Müller-Quernheim; R G Crystal
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

9.  Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factor.

Authors:  J G Lacronique; S I Rennard; P B Bitterman; T Ozaki; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1984-09

10.  Immunocompetent cells in bronchoalveolar lavage reflect the cell populations in transbronchial biopsies in pulmonary sarcoidosis.

Authors:  D A Campbell; L W Poulter; R M du Bois
Journal:  Am Rev Respir Dis       Date:  1985-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.